Showing 1 - 9 results of 9 for search 'Miki Ohira', query time: 0.06s Refine Results
  1. 1
    Comparative epigenomics by machine learning approach for neuroblastoma

    Comparative epigenomics by machine learning approach for neuroblastoma by Ryuichi P. Sugino, Miki Ohira, Sayaka P. Mansai, Takehiko Kamijo

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Robust Model Selection for Classification of Microarrays

    Robust Model Selection for Classification of Microarrays by Ikumi Suzuki, Takashi Takenouchi, Miki Ohira, Shigeyuki Oba, Shin Ishii

    Published 2009-01-01
    Get full text
    Article
  3. 3
    Robust Model Selection for Classification of Microarrays

    Robust Model Selection for Classification of Microarrays by Ikumi Suzuki, Takashi Takenouchi, Miki Ohira, Shigeyuki Oba, Shin Ishii

    Published 2009-01-01
    Get full text
    Article
  4. 4
    The PRC2 molecule EED is a target of epigenetic therapy for neuroblastoma

    The PRC2 molecule EED is a target of epigenetic therapy for neuroblastoma by Dilibaerguli Shaliman, Hisanori Takenobu, Ryuichi P. Sugino, Miki Ohira, Takehiko Kamijo

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1.

    Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1. by Eriko Isogai, Miki Ohira, Toshinori Ozaki, Shigeyuki Oba, Yohko Nakamura, Akira Nakagawara

    Published 2011-01-01
    Get full text
    Article
  6. 6
    ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors

    ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors by Sultana Parvin, Jesmin Akter, Hisanori Takenobu, Yutaka Katai, Shunpei Satoh, Ryu Okada, Masayuki Haruta, Kyosuke Mukae, Tomoko Wada, Miki Ohira, Kiyohiro Ando, Takehiko Kamijo

    Published 2023-04-01
    Get full text
    Article
  7. 7
    Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG)

    Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) by Miki Ohira, Yohko Nakamura, Tetsuya Takimoto, Atsuko Nakazawa, Tomoro Hishiki, Kimikazu Matsumoto, Hiroyuki Shichino, Tomoko Iehara, Hiroki Nagase, Takashi Fukushima, Akihiro Yoneda, Tatsuro Tajiri, Akira Nakagawara, Takehiko Kamijo

    Published 2021-12-01
    Get full text
    Article
  8. 8
    Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma

    Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma by Damini Chand, Yasuo Yamazaki, Kristina Ruuth, Christina Schönherr, Tommy Martinsson, Per Kogner, Edward F. Attiyeh, John Maris, Olena Morozova, Marco A. Marra, Miki Ohira, Akira Nakagawara, Per-Erik Sandström, Ruth H. Palmer, Bengt Hallberg

    Published 2013-03-01
    Get full text
    Article
  9. 9
    NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.

    NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas. by Yusuke Suenaga, S M Rafiqul Islam, Jennifer Alagu, Yoshiki Kaneko, Mamoru Kato, Yukichi Tanaka, Hidetada Kawana, Shamim Hossain, Daisuke Matsumoto, Mami Yamamoto, Wataru Shoji, Makiko Itami, Tatsuhiro Shibata, Yohko Nakamura, Miki Ohira, Seiki Haraguchi, Atsushi Takatori, Akira Nakagawara

    Published 2014-01-01
    Get full text
    Article

Search Tools: